PTGDR2 and blue cone monochromacy: Recent proteomics and transcriptomics from Lindskog et al. identified a new transmembrane G-protein-coupled receptor GPR44 (also known as CRTH2, PTGDR2, or CD294) posited as a promising biomarker for BCM monitoring [66].